查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866414

全球导管市场－2025-2030年预测

Global Catheters Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球导管市场预计将从 2025 年的 345.89 亿美元成长到 2030 年的 492.17 亿美元，复合年增长率为 7.31%。

未来五年，全球导尿管市场预计将保持强劲成长，主要驱动因素包括心血管疾病和泌尿系统疾病等慢性病盛行率的上升以及人口快速老化。导尿管是由硅橡胶、聚氯乙烯（PVC）和尼龙等材料製成的细管，在医疗保健领域中发挥至关重要的治疗和诊断作用。住院患者数量的增加以及对微创手术需求的成长是推动市场发展的因素。然而，导尿管相关感染疾病（例如尿道感染（CAUTI）和中央静脉导管相关血流感染疾病（CLABSI））以及先前疫情造成的干扰等挑战仍然是阻碍因素，因此需要技术创新来降低风险并提高患者安全。

市场驱动因素

不健康的生活方式导致慢性疾病的增加是推动导尿管需求成长的主要因素，其中心血管疾病和肾臟疾病特别突出。根据联合国预测，到2050年，65岁及以上人口将占世界人口的16%，人口老化显着推高了导尿管的需求，因为越来越多的老年人更容易患上需要使用导尿管的疾病，例如尿失禁和癌症。此外，因各种治疗而住院的患者人数不断增加，也进一步推高了导尿管的需求，尤其是在医疗服务水准不断提高的已开发国家和开发中国家。旨在透过先进材料和设计降低感染风险的创新也推动了市场成长。

市场限制

长期使用导尿管会增加感染风险，例如导尿管相关尿道感染(CAUTI) 和导尿管相关血流感染疾病(CLABSI)，这引发了患者的抵触情绪，限制了市场接受度。先进导尿管技术的高成本也可能限制低收入地区的病患使用。此外，过去全球卫生危机导致择期手术和住院治疗中断，暂时影响了市场需求，凸显了建立稳健供应链和製定感染防治策略的必要性。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 全球导管市场（按类型划分）

  • 介绍
  • 间歇性导尿管
  • 留置导管
  • 外导管
  • 心血管导管
  • 静脉导管
  • 神经血管导管
  • 透析导管
  • 消化道导管
  • 呼吸导管
  • 植入式导管
  • 其他的

6. 全球导管市场（依最终用户划分）

  • 介绍
  • 医院
  • 诊所
  • 诊断与介入放射中心
  • 门诊手术中心
  • 居家医疗
  • 长期照护机构
  • 復健中心
  • 其他的

7. 全球导管市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第九章：公司简介

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Abbott
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Medtronic
  • ConvaTec Group
  • Johnson & Johnson Services
  • Stryker
  • Terumo Corporation

第十章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061614012

The Global Catheters Market will surge from USD 34.589 billion in 2025 to USD 49.217 billion in 2030, registering a 7.31% compound annual growth rate (CAGR).

The global catheters market is poised for robust growth over the next five years, driven by the rising prevalence of chronic diseases, such as cardiovascular diseases and urological disorders, and a rapidly aging population. Catheters, thin tubes made from materials like silicone rubber, PVC, and nylon, are critical for therapeutic and diagnostic purposes in medical settings. The market is fueled by increasing hospitalizations and the growing need for minimally invasive procedures. However, challenges such as catheter-associated infections, including urinary tract infections (CAUTIs) and central line-associated bloodstream infections (CLABSIs), and disruptions from past pandemics pose restraints, necessitating innovation to mitigate risks and enhance patient safety.

Market Drivers

The escalating burden of chronic diseases, driven by unhealthy lifestyles, is a primary driver, with cardiovascular diseases and kidney disorders increasing demand for catheters. The aging global population, projected to reach 16% aged 65 and older by 2050 (United Nations), significantly boosts demand, as elderly individuals are more prone to conditions requiring catheters, such as urinary incontinence and cancer. Rising hospitalizations for various treatments further amplify the need for catheters, particularly in developed and developing economies with improving healthcare access. Innovations aimed at reducing infection risks through advanced materials and designs are also driving market growth.

Market Constraints

Prolonged catheter use raises concerns about infections like CAUTIs and CLABSIs, leading to patient reluctance and limiting market adoption. High costs of advanced catheter technologies may restrict access in low-income regions. Additionally, disruptions in elective surgeries and hospitalizations due to past global health crises have temporarily impacted demand, highlighting the need for resilient supply chains and infection-mitigation strategies.

Market Segmentation

The catheters market is segmented by type, end-user, and geography. Types include cardiovascular, urological, indwelling, intermittent, specialty, and implantable catheters, with cardiovascular and urological catheters leading due to high disease prevalence. End-users encompass hospitals, clinics, diagnostic imaging centers, and others, with hospitals dominating due to high patient volumes. Geographically, the market spans North America, Europe, Asia Pacific, South America, and the Middle East and Africa, with growth driven by regional healthcare needs and infrastructure.

Geographical Outlook

The Asia Pacific region is expected to witness strong growth, driven by the high prevalence of chronic diseases in countries like India and China, fueled by unhealthy lifestyles and aging populations. North America holds a significant share, supported by advanced healthcare infrastructure and the presence of major market players. Europe, South America, and the Middle East and Africa are projected to experience steady growth as healthcare access improves.

Competitive Landscape

Key players, including Boston Scientific, Medtronic, and Abbott, focus on R&D to develop advanced catheters with enhanced materials to reduce infection risks. Strategic partnerships and product launches are common to address evolving healthcare needs and maintain competitive advantages.

Opportunities and Challenges

Opportunities lie in expanding innovative catheter designs and targeting high-growth regions with rising healthcare demands. Challenges include mitigating infection risks and addressing cost barriers in developing markets. Industry experts should prioritize infection-resistant technologies and scalable solutions to capitalize on the catheters market's growth potential in a health-conscious global landscape.

The Catheters Market is analyzed into the following segments:

By Type

  • Intermittent Catheters
  • Indwelling Catheters
  • External Catheters
  • Cardiovascular Catheters
  • Intravenous Catheters
  • Neurovascular Catheters
  • Dialysis Catheters
  • Gastrointestinal Catheters
  • Respiratory Catheters
  • Implantable Catheters
  • Others

By End-User

  • Hospitals
  • Clinics
  • Diagnostic and Interventional Radiology Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Long-Term Care Facilities
  • Rehabilitation Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CATHETERS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Intermittent Catheters
  • 5.3. Indwelling Catheters
  • 5.4. External Catheters
  • 5.5. Cardiovascular Catheters
  • 5.6. Intravenous Catheters
  • 5.7. Neurovascular Catheters
  • 5.8. Dialysis Catheters
  • 5.9. Gastrointestinal Catheters
  • 5.10. Respiratory Catheters
  • 5.11. Implantable Catheters
  • 5.12. Others

6. GLOBAL CATHETERS MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Clinics
  • 6.4. Diagnostic and Interventional Radiology Centers
  • 6.5. Ambulatory Surgical Centers
  • 6.6. Home Care Settings
  • 6.7. Long-Term Care Facilities
  • 6.8. Rehabilitation Centers
  • 6.9. Others

7. GLOBAL CATHETERS MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
  • 9.2. B. Braun Melsungen AG
  • 9.3. Abbott
  • 9.4. Teleflex Incorporated
  • 9.5. Edwards Lifesciences Corporation
  • 9.6. Medtronic
  • 9.7. ConvaTec Group
  • 9.8. Johnson & Johnson Services
  • 9.9. Stryker
  • 9.10. Terumo Corporation

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations